ATE250414T1 - Pharmazeutische zubereitungen enthaltend eine kombination aus isosorbid-nitrat und acetylsalicylsaeure - Google Patents

Pharmazeutische zubereitungen enthaltend eine kombination aus isosorbid-nitrat und acetylsalicylsaeure

Info

Publication number
ATE250414T1
ATE250414T1 AT97945018T AT97945018T ATE250414T1 AT E250414 T1 ATE250414 T1 AT E250414T1 AT 97945018 T AT97945018 T AT 97945018T AT 97945018 T AT97945018 T AT 97945018T AT E250414 T1 ATE250414 T1 AT E250414T1
Authority
AT
Austria
Prior art keywords
isosorbide nitrate
phase
combination
pharmaceutical preparations
isosorbide
Prior art date
Application number
AT97945018T
Other languages
English (en)
Inventor
Ronald Brown Residence Miller
Stewart Thomas Leslie
Sandra Therese Antoi Malkowska
Derek Allan Prater
Original Assignee
Euro Celtique Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9621749.2A external-priority patent/GB9621749D0/en
Application filed by Euro Celtique Sa filed Critical Euro Celtique Sa
Application granted granted Critical
Publication of ATE250414T1 publication Critical patent/ATE250414T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/618—Salicylic acid; Derivatives thereof having the carboxyl group in position 1 esterified, e.g. salsalate
    • A61K31/621—Salicylic acid; Derivatives thereof having the carboxyl group in position 1 esterified, e.g. salsalate having the hydroxy group in position 2 esterified, e.g. benorylate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT97945018T 1996-10-18 1997-10-15 Pharmazeutische zubereitungen enthaltend eine kombination aus isosorbid-nitrat und acetylsalicylsaeure ATE250414T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9621749.2A GB9621749D0 (en) 1996-10-18 1996-10-18 Pharmaceutical combination formulation
GBGB9713549.5A GB9713549D0 (en) 1996-10-18 1997-06-26 Pharmaceutical combination formulation
PCT/GB1997/002849 WO1998017271A1 (en) 1996-10-18 1997-10-15 Pharmaceutical composition comprising a combination of isosorbide nitrate with acetylsalicylic acid

Publications (1)

Publication Number Publication Date
ATE250414T1 true ATE250414T1 (de) 2003-10-15

Family

ID=26310251

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97945018T ATE250414T1 (de) 1996-10-18 1997-10-15 Pharmazeutische zubereitungen enthaltend eine kombination aus isosorbid-nitrat und acetylsalicylsaeure

Country Status (6)

Country Link
EP (1) EP0930880B1 (de)
AT (1) ATE250414T1 (de)
AU (1) AU4633197A (de)
DE (1) DE69725155D1 (de)
GB (1) GB9713549D0 (de)
WO (1) WO1998017271A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR9905261A (pt) * 1999-09-30 2001-07-24 Libbs Farmaceutica Ltda Uma nova associação medicamentosa de liberação programada
CN105902509B (zh) * 2015-09-28 2018-08-17 天方药业有限公司 一种复方单硝酸异山梨酯缓释片及其制备方法
CN110559269A (zh) * 2019-08-15 2019-12-13 仁和堂药业有限公司 一种单硝酸异山梨酯片剂及其质量检测方法
CN110478328A (zh) * 2019-08-15 2019-11-22 仁和堂药业有限公司 单硝酸异山梨酯片的制备工艺

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61148115A (ja) * 1984-12-21 1986-07-05 Tooa Eiyoo Kk 難溶性薬物の徐放性製剤及びその製造法
ES2125342T3 (es) * 1992-07-30 1999-03-01 Cal Int Ltd Esteres y combinaciones de un nitrato organico y de un salicilato.
EP0654263B1 (de) * 1993-11-23 2002-01-23 Euro-Celtique S.A. Verfahren zur Herstellung einer Arzneizusammensetzung mit verzögerter Wirkstoffabgabe

Also Published As

Publication number Publication date
WO1998017271A1 (en) 1998-04-30
AU4633197A (en) 1998-05-15
DE69725155D1 (de) 2003-10-30
GB9713549D0 (en) 1997-09-03
EP0930880A1 (de) 1999-07-28
EP0930880B1 (de) 2003-09-24

Similar Documents

Publication Publication Date Title
US7939522B1 (en) Dosage formulations for acetylcholinesterase inhibitors
CA2307018A1 (en) Osmotic medicament releasing system
CA2389235A1 (en) Controlled release hydrocodone formulations
NO890194L (no) Galenisk middel.
CA2326517A1 (en) New galenic preparations of meloxicam for oral administration
ATE19589T1 (de) Pharmazeutische dreilagen-filmpraeparate mit lang anhaltender wirkung.
DK0724885T3 (da) Pernasal sammensætning og pernasalt præparat indeholdende dette
KR930009605A (ko) 소염 또는 진통제
Schor et al. Susadrin transmucosal tablets (nitroglycerin in Synchron® controlled-release base)
JPH1036269A (ja) 月経困難症及び／又は月経前症候群の軽減用薬剤
KR970032872A (ko) 아세틸살리실산을 함유하는 피부 손상 처치용 약물
ATE250414T1 (de) Pharmazeutische zubereitungen enthaltend eine kombination aus isosorbid-nitrat und acetylsalicylsaeure
CA2105541A1 (en) Programmed Release Tablets Containing Naproxen
HUP9802897A3 (en) Optically active pyridyl-4h-1,2,4-oxadiazine derivatives, the use thereof in the treatment of vascular diseases and pharmaceutical composition containing the compound as active ingredient
WO2003099214A3 (en) Biguanide formulations
CA2091134A1 (en) Therapeutic agent for threatened abortion
Samniah et al. Cerebral infarction associated with oral verapamil overdose
RU93004785A (ru) Твердые капсулы окфосфата цитарабина
KR910004181A (ko) 생체내 유효성을 증가시키는 신규의 제약학적 경구 투여 형태
CA2014659C (en) Pharmaceutical compositions for relief of dysmenorrhea and/or premenstrual syndrome and process
AU2004242546B2 (en) Dosage formulations for acetylcholinesterase inhibitors
RU2120284C1 (ru) Комбинированное противовоспалительное, анальгезирующее, жаропонижающее средство
KR970069034A (ko) 술린닥을 활성성분으로 함유하는 소염진통제의 서방성 제제
ATE257377T1 (de) Blister enthaltend ein transdermales therapeutisches system und eine einzeldosierte darreichungsform
TH41853A (th) การใช้ glp-1 หรือสารที่คล้ายคลึงในการบำบัดบริเวณหนึ่งของกล้ามเนื้อหัวใจตาย

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties